HIGHLIGHTS
- who: Anne Bull Haaversen from the Osaka Metropolitan University, Japan have published the article: Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with giant cell arteritis, in the Journal: Rheumatology (BSR) guidelines for diagnostics and treatment in GCA (17) served as the basis to the development of current guidelines. As the American College of Rheumatology guidelines recommend the use of Tocilizumab very early in the treatment of GCA patients, which is not refunded by the Norwegian Health Authorities, we chose not to incorporate these guidelines in the Norwegian guidelines (18). Also, the evidence on . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.